“EXPLORATION OF HYDROXYL SUBSTITUTED REGORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA THROUGH MOLECULAR DOCKING”. Frontier in Medical and Health Research 4, no. 3 (March 31, 2026): 3863–3874. Accessed November 9, 2026. https://fmhr.net/index.php/fmhr/article/view/3740.